Cbl regulates the activity of SIRT2

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 557-562

  Choi, You Hee ^a   Kim, Hangun ^b   Han, Younho ^a   Jin, Yun Hye ^a   Lee, Kwang Youl ^a  

^a Chonnam National University   (South Korea)

^b Sunchon National University   (South Korea)

Author keywords

Cbl; Protein stability; SIRT2; Ubiquitination

Indexed keywords

CBL PROTEIN; HISTONE DEACETYLASE; PROTEIN P53; SIRTUIN 1; SIRTUIN 2; TUBULIN; CBL PROTEIN, HUMAN; SIRT2 PROTEIN, HUMAN;

ARTICLE; DEACETYLATION; DOWN REGULATION; ENZYME ACTIVITY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MCF 7 CELL LINE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RING FINGER MOTIF; SIGNAL TRANSDUCTION; UBIQUITINATION; WESTERN BLOTTING; CELL LINE; METABOLISM; PHYSIOLOGY;

MAMMALIA;

CELL LINE; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-CBL; SIRTUIN 2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84918565533     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.125     Document Type: Article

References (37)

1. G. Blander, L. Guarente, The Sir2 family of protein deacetylases, Annu. Rev. Biochem. 73 (2004) 417-435.
2. M. Hernick, C.A. Fierke, Zinc hydrolases: the mechanisms of zinc-dependent deacetylases, Arch. Biochem. Biophys. 433 (2005) 71-84.
3. R. Marmorstein, Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases, Biochem. Soc. Trans. 32 (2004) 904-909.
4. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, W. Gu, Negative control of p53 by Sir2alpha promotes cell survival under stress, Cell 107 (2001) 137-148.
5. A. Vaquero, M. Scher, D. Lee, H. Erdjument-Bromage, P. Tempst, D. Reinberg, Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin, Mol. Cell 16 (2004) 93-105.
6. Y.H. Choi, H. Kim, S.H. Lee, Y.H. Jin, K.Y. Lee, Src regulates the activity of SIRT2, Biochem. Biophys. Res. Commun. 450 (2014) 1120-1125.
7. W.C. Horne, A. Sanjay, A. Bruzzaniti, R. Baron, The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function, Immunol. Rev. 208 (2005) 106-125.
8. A. Erdreich-Epstein, M. Liu, A.M. Kant, K.D. Izadi, J.A. Nolta, D.L. Durden, Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages, J. Leukoc. Biol. 65 (1999) 523-534.
9. T. Shintani, F. Ohara-Waki, A. Kitanaka, T. Tanaka, Y. Kubota, Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase, Blood Cells Mol. Dis. (2014), http://dx.doi.org/10.1016/j.bcmd.2014.06.005 (Epub ahead of print).
10. S. Tanaka, M. Amling, L. Neff, A. Peyman, E. Uhlmann, J.B. Levy, R. Baron, C-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption, Nature 383 (1996) 528-531.
11. J.J. Song, J.H. Kim, B.K. Sun, M.A. Alcala Jr., D.L. Bartlett, Y.J. Lee, C-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment, Cell. Signal. 22 (2010) 377-385.
12. I. Fernow, A. Tomasovic, A. Siehoff-Icking, R. Tikkanen, Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases, BMC Cell Biol. 10 (2009) 80.
13. S.C. Dryden, F.A. Nahhas, J.E. Nowak, A.S. Goustin, M.A. Tainsky, Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle, Mol. Cell. Biol. 23 (2003) 3173-3185.
14. F. Nahhas, S.C. Dryden, J. Abrams, M.A. Tainsky, Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin, Mol. Cell. Biochem. 303 (2007) 221-230.
15. K.C. Pramanik, N.M. Fofaria, P. Gupta, S.K. Srivastava, CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT, Mol. Cancer Ther. 13 (2014) 687-698.
16. Y.H. Jin, Y.J. Kim, D.W. Kim, K.H. Baek, B.Y. Kang, C.Y. Yeo, K.Y. Lee, Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53, Biochem. Biophys. Res. Commun. 368 (2008) 690-695.
17. B. Peck, C.Y. Chen, K.K. Ho, P. Di Fruscia, S.S. Myatt, R.C. Coombes, M.J. Fuchter, C.D. Hsiao, E.W. Lam, SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2, Mol. Cancer Ther. 9 (2010) 844-855.
18. J.C. Black, A. Mosley, T. Kitada, M. Washburn, M. Carey, The SIRT2 deacetylase regulates autoacetylation of p300, Mol. Cell 32 (2008) 449-455.
19. Y. Han, Y.H. Jin, Y.J. Kim, B.Y. Kang, H.J. Choi, D.W. Kim, C.Y. Yeo, K.Y. Lee, Acetylation of Sirt2 by p300 attenuates its deacetylase activity, Biochem. Biophys. Res. Commun. 375 (2008) 576-580.
20. C.B. Thien, W.Y. Langdon, C-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses, Biochem J 391 (2005) 153-166.
21. C.B. Thien, W.Y. Langdon, Negative regulation of PTK signalling by Cbl proteins, Growth Factors 23 (2005) 161-167.
22. C.B.F. Thien, W.Y. Langdon, C-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses, Biochem. J. 391 (2005) 153-166.
23. M.L. Lupher Jr., N. Rao, M.J. Eck, H. Band, The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction, Immunol. Today 20 (1999) 375-382.
24. C.B. Thien, W.Y. Langdon, Cbl: many adaptations to regulate protein tyrosine kinases, Nat. Rev. Mol. Cell Biol. 2 (2001) 294-307.
25. S.C. Bae, Y.H. Lee, Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation, Gene 366 (2006) 58-66.
26. B.J. North, E. Verdin, Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation, J. Biol. Chem. 282 (2007) 19546-19555.
27. Y.H. Choi, H. Kim, S.H. Lee, Y.H. Jin, K.Y. Lee, ERK1/2 regulates SIRT2 deacetylase activity, Biochem. Biophys. Res. Commun. 437 (2013) 245-249.
28. J.H. Kim, K. Kim, H.M. Jin, I. Song, B.U. Youn, S.H. Lee, Y. Choi, N. Kim, Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1, J. Biol. Chem. 285 (2010) 5224-5231.
29. B.J. North, B.L. Marshall, M.T. Borra, J.M. Denu, E. Verdin, The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase, Mol. Cell 11 (2003) 437-444.
30. J. von Kampen, M. Wettern, Ubiquitin-dependent degradation and modification of proteins, Naturwissenschaften 79 (1992) 163-170.
31. Y. Li, H. Matsumori, Y. Nakayama, M. Osaki, H. Kojima, A. Kurimasa, H. Ito, S. Mori, M. Katoh, M. Oshimura, T. Inoue, SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis, Genes Cells 16 (2011) 34-45.
32. T. Inoue, M. Hiratsuka, M. Osaki, M. Oshimura, The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation, Cell Cycle 6 (2007) 1011-1018.
33. C. Das, M.S. Lucia, K.C. Hansen, J.K. Tyler, CBP/p300-mediated acetylation of histone H3 on lysine 56, Nature 459 (2009) 113-117.
34. C.L. Brooks, W. Gu, The impact of acetylation and deacetylation on the p53 pathway, Protein Cell 2 (2011) 456-462.
35. M.H. Yang, G. Laurent, A.S. Bause, R. Spang, N. German, M.C. Haigis, K.M. Haigis, HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS, Mol. Cancer Res. 11 (2013) 1072-1077.
36. C.M. Southwood, M. Peppi, S. Dryden, M.A. Tainsky, A. Gow, Microtubule deacetylases, SirT2 and HDAC6, in the nervous system, Neurochem. Res. 32 (2007) 187-195.
37. N. Severe, F.X. Dieudonne, C. Marty, D. Modrowski, A. Patino-Garcia, F. Lecanda, O. Fromigue, P.J. Marie, Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis, J. Bone Miner. Res. 27 (2012) 2108-2117.